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tor in the brain and its subunits originate from diﬀerent
genes or gene families (a1–a6, b1–b3, c1–c3, d, e, h, p, or
q1–3). In the mouse brain the anatomical distribution of
GABAA receptor subunit mRNAs so far investigated is
restricted to subunits forming benzodiazepine-sensitive
receptor complexes (a1–a3, a5, b2, b3 and c2) in the fore-
brain and midbrain as assessed by in situ hybridization
(ISH). In the present study the anatomical distribution of
the GABAA receptor subunits a1–a6, b1–b3, c1–c2 and d
was analyzed in the mouse brain (excluding brain stem) by
ISH and immunohistochemistry (IHC). In several brain areas
such as hippocampus, cerebellum, bulbus olfactorius and
habenula we observed that mRNA levels did not reﬂect pro-
tein levels, indicating that the protein is located far distantly
from the cell body. We also compared the distribution of
these 12 subunit mRNAs and proteins with that reported in
the rat brain. Although in general there is a considerable
correspondence in the distribution between mouse and rat
brains, several species-speciﬁc diﬀerences were observed.
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The GABAA receptor is the main inhibitory receptor in the
brain. It is composed of ﬁve subunits that form a central
chloride channel. Depending on the chloride gradient at
the cell membrane that is built up by the chloride
transporters NKCC1 and KCC2 (Owens and Kriegstein,
2002), stimulation of the GABAA receptor by GABA
results in a hyperpolarizing (chloride inﬂux). Under
conditions of high intracellular chloride concentrations
stimulation of the GABAA receptor can also result in
depolarization. GABAA receptor subunits originate from
diﬀerent genes or gene families (a1–a6, b1–b3, c1–c3,
d, e, h, p, or q1–3). The majority of GABA receptors in
the brain consists of two a-subunits, two b-subunits and
one c- or d-subunit. The most abundant subunit
combination consists of two a1-, two b2-subunits and
one c2-subunit. The subunit constitution determines the
physiological and pharmacological properties of the
GABAA receptors. Thus GABAA receptors containing
subunits a1, a2, a3, or a5, together with two b subunits
and a c subunit respond to benzodiazepines or the
hypnotic substance zolpidem. These and other
compounds exert their action via the benzodiazepine-
binding site, located at the ac interface of GABAA
receptors (Richter et al., 2012). The two GABA binding
sites of these receptors are located at the two ba
interfaces (Ernst et al., 2003).
In the rat brain the distribution of the various GABAA
receptor subunit mRNAs and proteins has been
examined in detail (Laurie et al., 1992; Wisden et al.,
1992; Fritschy and Mohler, 1995; Sperk et al., 1997;
Tsunashima et al., 1997; Pirker et al., 2000; Schwarzer
et al., 2001). In the mouse brain knowledge of the
anatomical distribution of mRNAs of the GABAA
receptor subunits is focused on those forming
benzodiazepine-sensitive receptor complexes (a1–a3,
a5, b2, b3 and c2) in the fore- and midbrain, without
inclusion of the bulbus olfactorius and cerebellum (Heldt
and Ressler, 2007a). Each gene has been shown to
have a unique region-speciﬁc distribution pattern. The
distribution of other subunit mRNAs and proteins (a4,
a6, b1, c1 and d) has been studied in individual brain
regions of the mouse brain so far (e.g. Kato, 1990;
Jones et al., 1997; Peng et al., 2002, 2004; Prenosil
et al., 2006; Sassoe`-Pognetto et al., 2009; Tasan et al.,
2011; Marowsky et al., 2012).
It is noteworthy that the benzodiazepine-insensitive
a4-, a6- and d-subunits are predominantly or exclusively
extrasynaptic providing preferentially tonic inhibition (forNC-ND license.
Table 1. Oligonucleotide sequence for in situ hybridization
mRNA Access code Oligonucleotide sequence
a1 NM_010250.3 50 CCT GGC TAA GTT AGG GGT ATA GCT GGT TGC TGT AGG AGC ATA TGT 30
a2 NM_008066.3 50 CAT CGG GAG CAA CCT GAA CGG AGT CAG AAG CAT TGT AAG TCC 30
a3 NM_008067.3 50 GGC CAG ATT GAT AGG ATA GGT GGT ACC CAC TAT GTT GAA GGT GGT G 30
a4 NM_010251.2 50 GGA TGT TTC TGT GTG TTT CTC CTT CAG CAC AGG AGC AGC TGG 30
a5 NM_176942.3 50 TTG GGA TGT TTG GAG GAT GGG TCA GCT TTC CAG TTG T 30
a6 NM_001099641 50 GCT GAT TCT CTT CTT CAG ATG GTA CTT GGA GTC AGA GTG CAC AAC 30
b1 NM_008069.4 50 TGC CTG TCC AGC CCA CGC CCG AAG CCC TCG CGG CTG CTC AGT GG 30
b2 NM_008070.3 50 ACT GTT TGA AGA GGA ATC CAG TCC TTG CTT CTC ACG GAA GGC TG 30
b3 NM_001038701.1 50 CTG TCT CCC ATG TAC CGC CCA TGC CCT TCC TTG GGC ATG CTC TGT 30
c1 NM_010252.4 50 GGG AAT GAG AGT GGA TCC AGC ATG GAG ACC TGG GGA 30
c2 NM_008073.2 50 GGC AAT GCG AAT ATG TAT CCT CCC ATG TCT CCA GGC TCC TGT TCG GC 30
d NM_008072.1 50 GGC AAG GTC CAT GTC ACA GGC CAC TGT GGA GGT GAT GCG GAT GCT GTA T 30
Table 2. Identity, source and characterization of antibodies
GABAA receptor
subunit
Code Host Epitope Protein concentration
(lg/ml)
Dilution for IHC Incubation Previously used
in study
a1-subunit a1N Rabbit residue 1–9 592 1:150 72 h at 4 C
a2-subunit a2C Rabbit residue 416–424 540 1:100 24 h at RT
a2-subunit a2L Rabbit residue 322–357 290 1:15 72 h at 4 C 4
a3-subunit a3N Rabbit residue 1–11 837 1:150 24 h at RT 1, 2
a4-subunit a4N Rabbit residue 1–14 600 1:300 72 h at 4 C
a4-subunit a4L Rabbit residue 379–421 623 1:2000 72 h at 4 C 4
a5-subunit a5L Rabbit residue 337–380 410 1:100 24 h at RT 3
a6-subunit a6 Rabbit residue 429–434 350 1:70 72 h at 4 C 1, 2
b1-subunit b1L Rabbit residue 350–404 360 1:300 72 h at 4 C
b1-subunit b1L2 Rabbit residue 350–375 453 1:200 24 h at RT 4
b2-subunit b2L Rabbit residue 351–404 684 1:200 24 h at RT 5
b3-subunit b3L Rabbit residue 345–408 479 1:200 24 h at RT 4, 5
c1-subunit c1L Rabbit residue 324–366 210 1:100 24 h at RT 1, 2
c2-subunit c2L Rabbit residue 319–366 270 1:300 72 h at 4 C
d-subunit dN Rabbit residue 1–44 449 1:300 72 h at 4 C 1, 2, 3
RT: room temperature; IHC: immunohistochemistry.
The respective antibodies were previously used in the following studies:
1. Sperk et al. (1997), rat; 2. Pirker et al. (2000), rat; 3. Scimemi et al. (2005), rat; 4. Tasan et al. (2010), mouse; 5. Pirker et al. (2003), human.
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knowledge of their anatomical distribution in the mouse
brain is of considerable importance. In the rat the d
subunit is known to form receptors speciﬁcally with the
a6- and b2/3-subunits in cerebellar granule cells and with
a4 and bx in several areas of the forebrain including
thalamus, neostriatum and dentate gyrus (for review see
Farrant and Nusser, 2005). Interestingly, in mice a4-,
a5-, a6- and d-subunit-containing GABAA receptors were
shown to be present exclusively in the extrasynaptic
somatic and dendritic membranes of cerebellar granule
cells as well as extrasynaptic and peri-synaptic locations
in hippocampal dentate gyrus granule cells (Wie et al.,
2003). These predominantly extrasynaptic GABAA
receptors are sensitive to neurosteroids and have been
implicated in altered seizure susceptibility and altered
states of anxiety during the ovarian cycle and in
postpartum depression (Maguire et al., 2005; Maguire
and Mody, 2008). Recent evidence indicates that
mutations of the d-subunit-containing GABAA receptorsare associated with a reduction in channel open duration,
resulting in an increased neuronal excitability and thus
contributing to the common generalized epilepsies (Feng
et al., 2006; Lu and Wang, 2009). In addition, evidence
for a role for tonic inhibition mediated by d subunit-
containing GABAA receptors in neuroprotection against
excitotoxic insults in the adult mice striatum has been
provided (Santhakumar et al., 2010).
Signiﬁcant diﬀerences in GABAA receptor composition
between rat and mouse brain have been detected.
Particular brain areas of mRNA variance between mice
and rats include the subthalamic nucleus, medial
septum, thalamus and amygdala (Heldt and Ressler,
2007a). The total percentage of d-containing receptors
in mouse cerebellum was signiﬁcantly higher than in the
rat cerebellum (Po¨ltl et al., 2003).
Discrepancies also exist concerning the presence of
the a5-subunit in the cerebellum of rat and mouse.
According to Laurie et al. (1992) a5-subunit mRNA is
not detectable in the rat cerebellum, whereas the
Fig. 1. Distribution of the GABAA receptor subunit mRNAs (a1–a6, b1–b3, c1, c2 and d) in horizontal sections of the mouse brain at the level of
Bregma 3.60 to 4.00 mm (according to Franklin and Paxinos, 2007). Note the widespread distribution of a1-, b2- and c2-subunit mRNAs in this
horizontal section of the brain. a4- and d-subunit mRNAs are co-localized in the striatum, thalamus and bulbus olfactorius, but not in the cerebellum.
Expression of a6-subunit mRNA was restricted to the cerebellum. Scale bar = 2 mm.
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granule cells (Persohn et al., 1992). On the protein
basis small but signiﬁcant quantities of a5-subunit
protein seem to be present in rat, but not in mouse
(Po¨ltl et al., 2003) and moderate immunoreactivity was
detected throughout the rat cerebellum (Pirker et al.,
2000). On the other hand, on mapping the rat brain
distribution of a5 subunit-containing GABAA receptors
using quantitative autoradiography with the a5-selective
ligand [3H]L-655,708, no binding was detected in the
cerebellum (Sur et al., 1999).
The aim of the present investigation was to complete
the anatomical distribution of mRNAs for 12 GABAA
receptor subunits in the mouse brain by in situ
hybridization (ISH) and to deﬁne the anatomical
distribution of these GABAA receptor subunits at theprotein level by immunohistochemistry (IHC). The
juxtaposition of ISH and IHC results will provide a better
overview about synthesis and ﬁnal location of each
individual subunit. Moreover, diﬀerences in the
distribution of GABAA receptor subunits in the mouse
and rat brains will be discussed at the mRNA and
protein level.EXPERIMENTAL PROCEDURES
Animals
All procedures involving animals and animal care were
conducted in accordance with international laws and policies
(EEC Council Directive 86/609, OJ L 358, 1, December 12,
1987; Guide for the Care and use of Laboratory Animals, U.S.
Fig. 2. Distribution of the GABAA receptor subunit immunoreactivities (a1–a6, b1–b3, c1, c2 and d) in horizontal sections of the mouse brain at the
level of Bregma 3.60 mm (according to Franklin and Paxinos, 2007). In general, the localization of the protein resembled that of mRNA. Note the
widespread distribution of a1- and b2-subunits. In contrast to mRNA labeling the immunoreactiv for c2 was less intense in the striatal and thalamic
area. a4- and d-subunit proteins are co-localized in the striatum, thalamus and bulbus olfactorius, but not in the cerebellum. The arrow indicates the
immunoreactivity of the a6-subunit in the cerebellum. Scale bar = 2 mm.
348 H. Ho¨rtnagl et al. / Neuroscience 236 (2013) 345–372National Research Council, 1996) and were approved by the
Austrian Ministry of Science. All eﬀort was taken to minimize
the number of animals used and their suﬀering.
Experiments were carried out on adult male C57Bl/6NCrl
mice (n= 23) at 12–15 weeks of age obtained from Charles
River (Charles River, Sulzfeld, Germany) and consequently
bred in the animal facility of the Department of Pharma-
cology, Medical University of Innsbruck, Austria. Animals
were housed under standard laboratory conditions (12:12 h
light/dark cycle with lights on at 7:00) with food and water
available ad libitum. Mice were housed in groups of 4–5
animals per cage.Histochemistry
Tissue preparation. Mice were killed by carbon dioxide gas
inhalation or by injecting an overdose of thiopental (Thiopental,
Sandoz, Austria) for ISH or IHC, respectively. Brains wereeither snap frozen (isopentane, 70 C, 3 min) for ISH or
perfused with 4% paraformaldehyde for IHC (Tasan et al.,
2010). Using a cryostat, coronal sections of 20 and 40 lm
were cut for ISH and IHC, respectively. Every 7th section was
Nissl stained and a series of matching sections were selected
for subsequent histochemistry.
ISH. ISH was performed as described previously in detail
(Tsunashima et al., 1997; Tasan et al., 2010). Oligonucleotide
probes targeting diverse subunits of the GABAA receptor are
listed in Table 1. They were custom synthesized (Microsynth,
Balgach, Switzerland, puriﬁed by HPLC). Oligonucleotides
(2.5 pmol) were 30 end-labeled by incubation with [35S]a-dATP
(50 lCi; 1300 Ci/mmol, Hartmann Analytic GmbH,
Braunschweig, Germany) and terminal transferase (Roche
Diagnostics, Basel, Switzerland), as described previously in
detail (Tsunashima et al., 1997). Hybridization was performed
in 50% formamide, 4 SSC (1 SSC is 150 mM NaCl, 15 mM
sodium citrate, pH 7.2), 500 lg/ml salmon sperm DNA,
Fig. 3. Distribution of the GABAA receptor subunit mRNAs (a1–a6, b1–b3, c1, c2 and d) in horizontal sections of the mouse brain at the level of
Bregma 2.56 to 2.36 mm (according to Franklin and Paxinos, 2007). Note the widespread distribution of a1, b2 and c2 mRNAs in this horizontal
section of the brain. a4 and d mRNAs are co-localized in the striatum, thalamus and bulbus olfactorius, but not in the cerebellum. Expression of a6
mRNA was restricted to the cerebellum. In the hippocampus strong labeling occurs especially for a2, a5 and b2. Scale bar = 2 mm.
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0.02% polyvinylpyrrolidone, and 0.02% bovine serum albumin),
10% dextran sulfate, and 20 mM dithiothreitol (all from Sigma)
at 42 C for 18 h. The slides containing the sections were
washed at stringent conditions (50% formamide in 2 SSC,
42 C) and brieﬂy rinsed in water followed by 70% ethanol, and
dried. Sections were exposed to BioMax MR ﬁlms (Amersham
Pharmacia Biotech, Buckinghamshire, UK) together with [14C]-
microscales for 7 to 14 days. The BioMax MR ﬁlms were
developed with Kodak D19 developer. Sections were
counterstained with Cresyl Violet, dehydrated, cleared in butyl
acetate, and covered with a coverslip using Eukitt (Merck,
Darmstadt, Germany).
Semi-quantitative evaluation of ISH was done using digitized
images of the autoradiographs (Epson Perfection 4870 Photo;
eight bit digitized picture, 256 gray values). Gray values were
measured by the public domain program ImageJ 1.38x (NIH,
USA; 255 = white; 0 = black) and converted to relative optical
density. Relative optical density values obtained from
autoradiographic images were plotted against standard curves
obtained from images of [14C]-microscales exposed to the
same ﬁlm to ensure that signal values are within the linear
range of radioactivity. Each value was obtained from the
innermost 90% of the respective brain area. Adjacent
background levels with no hybridization signal (internal capsule)
were obtained separately for each brain section and side. Theanatomical level was veriﬁed in sections counterstained with
Cresyl Violet using a mouse brain atlas (Franklin and Paxinos,
2007).
IHC. Immunohistochemical analysis was performed on free-
ﬂoating, paraformaldehyde-ﬁxed, 40-lm thick coronal sections
using indirect peroxidase labeling, as described previously
(Tasan et al., 2011). Polyclonal rabbit antisera against the
indicated residues of the GABAA receptor subunits used are
listed in Table 2.
In brief, free-ﬂoating coronal sections were incubated in
10% normal goat serum (Biomedica, Vienna, Austria) in
Tris–HCl-buﬀered saline (TBS; 50 mM, pH 7.2) for 90 min,
followed by incubation with primary antiserum (24 h at room
temperature or 72 h at 4 C as indicated for the diﬀerent
GABAA receptor subunits). The resulting complex was
visualized by incubation with horseradish peroxidase-
coupled secondary antibody (1:250 P0448; Dako, Vienna,
Austria) at room temperature for 150 min. Sections were
further incubated in a solution containing 0.03% 3,30-
diaminobenzidine tetrahydrochloride (Sigma, St. Louis, MO)
and 0.005% H2O2 in TBS for 6 min. They were then mounted
on slides, air-dried, dehydrated and coverslipped. After each
incubation step (with the exception of preincubation with 10%
normal goat serum), sections were washed three times for
5 min each with TBS. All buﬀers and antibody dilutions,
Fig. 4. Distribution of the GABAA receptor subunit immunoreactivities (a1–a6, b1–b3, c1, c2 and d) in horizontal sections of the mouse brain at the
level of Bregma 2.56 to 2.36 mm (according to Franklin and Paxinos, 2007). In general, the localization of the protein resembled that of mRNA.
Note the widespread distribution of a1- and b2-subunits. In contrast to mRNA labeling the immunoreactiv for c2 was less intense in the striatal and
thalamic area. a4 and d proteins are co-localized in the striatum and thalamus, but not in the cerebellum and CA1–CA3 of the hippocampus. The
immunoreactivity of the a6-subunit is restricted to the cerebellum. Scale bar = 2 mm.
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and the diaminobenzidine reaction buﬀer, contained 0.4%
Triton X-100. Normal goat serum (10%) was included in all
buﬀers containing antibodies. In each experiment, sections
without primary antibody were included as a control. No
immuno-positive elements were detected in these control
sections.
Knock out mice were provided by Dr. Delia Belelli,
Neurosciences Institute, Division of Pathology and
Neuroscience, University of Dundee, UK for subunit a2
(Panzanelli et al., 2011) and b2 (Blednov et al., 2003), by
Prof. Jean-Marc Fritschy, Institute of Pharmacology and
Toxicology, University of Zurich, Switzerland for subunit a3
(Winsky-Sommerer et al., 2008) and by Dr. Gregg E.
Homanics, Departments of Anesthesiology/Critical Care
Medicine, University of Pittsburgh School of Medicine, USA
for subunit d (Mihalek et al., 1999). The animals were
perfused with paraformaldehyde as described above, 40lm
sections were obtained at the level of the dorsal
hippocampus and the amygdala and incubated (together
with sections from wild type mice) with the respective
antibodies. Whereas the sections from wild type mice
revealed clear labeling of the respective GABAA receptor
subunits, no labeling was obtained in the respective knock
out mice.RESULTS
Overall distribution of individual GABAA receptor
subunits at the mRNA and protein level
In Figs. 1–6 the overall mRNA and protein distribution of
12 diﬀerent GABAA receptor subunits in the mouse
brain is presented in two horizontal and one sagittal
section. In general, the localization of mRNA resembled
that of the protein. The regional distribution of the
individual GABAA receptor subunit was rather
heterogeneous. The localization of the a6 subunit
mRNA and immunoreactivity was largely restricted to
the cerebellum, where mRNA and protein were
abundantly expressed. A faint immunoreactivity of the
a6-subunit was also detected in the dorsal cochlear
nucleus and spinal trigeminal tract (see Fig. 6). With the
exception of the striatum, the a1-, b2- and c2-subunits
displayed the most widely distributed mRNAs and
immunoreactivities. This distribution is in good
agreement with previous ISH data and
immunohistochemical data in the rat brain. With the
Fig. 5. Distribution of the GABAA receptor subunit mRNAs (a1–a6, b1–b3, c1, c2 and d) in sagittal sections of the mouse brain approximately at the
lateral level 1.20 mm (according to Franklin and Paxinos, 2007). Note the widespread distribution of a1-, b2- and c2-subunit mRNAs in this sagittal
section of the brain. a4- and d-subunit mRNAs are co-localized in the striatum and thalamus but not in the cerebellum. Expression of a6 mRNA was
restricted to the cerebellum. Note the strong label of a1-and b2-subunit in the dorsal subiculum (DS). Scale bar = 2 mm.
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olfactorius closely matching distribution patterns of a4
and d subunit mRNAs and immunoreactivities were
obtained. An overlapping distribution was also observed
for a2- and b3-subunits. The a3-subunit had a unique
distribution especially concerning the hippocampus and
thalamus, which did not match that of any other subunit.Distribution of GABAA receptor subunits in the
cortical areas of the mouse
In the neocortex no evidence for the expression of the
a6-subunit was found. The labeling for the c1-subunit
was very faint especially in the ISH. All other subunitswere widely distributed throughout the cortical areas
including piriform cortex and endopiriform nucleus,
entorhinal and perirhinal cortices (summarized in
Table 3). In general a good correspondence between
the ISH and immunohistochemical signal was obvious.
With the exception of the subunits a6, c1, and d a high
expression of mRNA and protein was found in the
piriform, entorhinal and perirhinal cortices.Distribution of GABAA receptor subunits in the
mouse hippocampal formation
In the hippocampus a clear dissociation between the
location of mRNAs and proteins was observed. ISH
Fig. 6. Distribution of the GABAA receptor subunit immunoreactivities (a1–a6, b1–b3, c1, c2 and d) in sagittal sections of the mouse brain
approximately at the lateral level 1.20 mm (according to Franklin and Paxinos, 2007). In general, the localization of the protein resembled that of
mRNA. Note the widespread distribution of a1- and b2-subunits. In contrast to mRNA labeling the immunoreactiv for c2 was less intense in the
striatal and thalamic area. a4 and d proteins are co-localized in the striatum and thalamus, but not in the cerebellum and CA1–CA3 of the
hippocampus. The immunoreactivity of the a6-subunit is restricted to the cerebellum and the spinal trigeminal tract (STT). Note the strong label of
a1-, b2- and c2-subunits in the dorsal subiculum (DS). Scale bar = 2 mm.
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ammonis (CA) CA1 to CA3, the granule cell layer and the
hilus of the dentate gyrus. Immunohistochemical labeling,
however, was predominantly found in the respective
dendritic ﬁelds, the strata oriens and radiatum of CA1 to
CA3 and in the molecular layer of the dentate gyrus
(see Figs. 7–9; Table 4). Within the hippocampal
formation ISH signals and labeling intensity of the
immunoreactive proteins appeared to be diﬀerent for
individual subunits.The a1 mRNA and protein were both abundantly
found in the dentate gyrus and hilus, CA1 region as well
as in the dorsal (Figs. 5 and 6) and ventral subiculum
(Fig. 9), whereas the expression in the CA3 area was
considerably weaker.
The a2-subunit was present in all subﬁelds of the
hippocampus including the dentate hilus with the highest
concentrations in the dentate gyrus and area CA3, both
at the mRNA and protein level. The concentrations in
the ventral subiculum were much lower than in other
Table 3. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d in
various regions of the mouse cerebral cortex
Cerebral cortex a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Layer 1 + + ++ ++ ++ ++ ++ +++ (+) ++ – –
Layer 2 ++ + ++ ++ ++ ++ ++ +++ (+) (+) – –
Layer 3 ++ + ++ + ++ + ++ +++ (+) (+)
Layer4 +++ +++ +(+) + (+) (+) ++ ++ (+) (+) – –
Layer 5 + + + + ++(+) ++ + + +(+) ++ – –
Layer 6 ++ ++ + + ++(+) ++ ++ + + + – –
Piriform cortex +++ +++ +++ +++ +++ +++ +++ +++ +(+) ++ – –
Endopiriform nuc + +++ + + +++ +++ (+) + +++ +++ – –
Entorhinal cortex ++(+) +++ ++ +(+) ++ +++ +(+) +++ +++ +++ – –
Perirhinal cortex ++ +++ ++ +(+) ++ +++ +(+) +++ +++ +++ – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Layer 1 + + ++ + ++ ++ (+) + + ++ ++ ++
Layer 2 +(+) + ++ + +(+) + (+) + +(+) + ++ ++
Layer 3 +(+) + ++ + +(+) + (+) + +(+) + ++ ++
Layer4 ++ ++ +++ +++ ++ + (+) + ++(+) ++ ++ ++
Layer 5 + + + + + ++ (+) (+) +(+) + + +
Layer 6 ++ ++ ++ + ++ + (+) + +(+) + +(+) +
Piriform cortex +++ ++ +++ +++ +++ +++ (+) + ++ +++ ++ ++
Endopiriform nuc +++ +++ ++ +++ ++ +++ (+) + +(+) ++ (+) +
Entorhinal cortex +++ +++ +(+) +++ ++ +++ (+) + ++ +++ (+) +
Perirhinal cortex +++ +++ +(+) +++ ++ +++ (+) + ++ +++ (+) +
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling.
Fig. 7. Distribution of the GABAA receptor subunit mRNAs (a1–a6, b1–b3, c1, c2 and d) in the dorsal hippocampus (coronal sections of the mouse
brain approximately Bregma 1.82 mm, according to Franklin and Paxinos, 2007). In situ hybridization signals were restricted to the pyramidal cell
layer of cornu ammonis CA1 to CA3, the granule cell layer and the hilus of dentate gyrus. Note the strong signals of a2-, a5- and b3-subunits
throughout the hippocampus. a1-subunit mRNA labeling was weak in the CA3 area in comparison to a strong label in CA1 and dentate gyrus. a3-
subunit mRNA was weakly expressed and restricted to CA1, whereas d-subunit mRNA was almost exclusively restricted to the dentate gyrus. Scale
bar = 300 lm. DG= dentate gyrus.
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Fig. 8. Distribution of the GABAA receptor subunit immunoreactivities (a1–a6, b1–b3, c1, c2 and d) in the dorsal hippocampus (coronal sections of
the mouse brain approximately Bregma 1.82 mm, according to Franklin and Paxinos, 2007). Immunohistochemical labeling was predominantly
found in the respective dendritic ﬁelds, the strata oriens (so) and radiatum (sr) of CA1 to CA3 and in the molecular layer (ml) of the dentate gyrus.
Note the faint labeling of the a3-subunit restricted to the CA1 region. A strong expression of a2- and a5-subunits occurred throughout the
hippocampus proper with highest intensity in the CA3 area. Note the co-distribution of a4- and d-subunit protein in the dentate gyrus, but not in the
CA1–CA3 region. Scale bar = 300 lm. h = hilus.
354 H. Ho¨rtnagl et al. / Neuroscience 236 (2013) 345–372parts of the hippocampal formation and almost no signals
were present in the dorsal subiculum.
Similar to that seen in the rat brain the a3-subunit was
beside a6- and c1-subunits the least expressed subunit in
the hippocampus. ThemRNA signal was restricted to CA1,
where a very faint immunohistochemical labeling was
found. In contrast, strong labeling of both ISH and IHC
was found in the ventral (Fig. 9) and dorsal subiculum
and moderate labeling in the hilus of the dentate gyrus.
For the a4-subunit strong labeling was observed in
the granule cell layer and molecular layer of the DG by ISH
and IHC, respectively. In CA1 to CA3 the concentration was
lower and no signal was detected in the hilus. In the ventral
and dorsal subiculum only a faint signal was present.
The a5-subunit displayed a distribution within the
hippocampus, and ventral and dorsal subiculum similar
to the a2-subunit with the strongest signals of both ISH
and IHC in the CA3 area and the dentate gyrus. Almost
no labeling was observed in the ventral and dorsal
subiculum and dentate hilus.
The b-subunit mRNAs and proteins were present
throughout the hippocampus including subiculum.
Labeling for the b2-subunit very much resembled that of
the a1-subunit.
For the c1-subunit no ISH signal, and similar to that
seen in the rat, only a very faint and diﬀuse immunoreactivity
was detected throughout the hippocampus. The c2-subunit
provided mRNA signals and immunohistochemical
labeling with equal intensity throughout the hippocampus.The distribution of the d-subunit in the hippocampus
and subiculum was almost exclusively restricted to the
dentata gyrus with only a very faint signal in the CA1
area. No labeling was found in the CA3 area, in the
ventral and dorsal subiculum and in the hilus of the
dentate gyrus.
Distribution of GABAA receptor subunits in the
mouse striatal and pallidal areas
Similar to that seen in the rat a frequently complementary
distribution of individual subunits within diﬀerent nuclei of
the basal ganglia was detected. The subunits a2, a4, b3
and d were considerably more concentrated in the
striatum and the associated brain areas of nucleus
accumbens core and shell than in the globus pallidus
and entopeduncular nucleus (Fig. 12) both on the level
of mRNA and protein. In contrast, the globus pallidus
and its related brain nuclei, entopeduncular nucleus and
ventral pallidum displayed considerably stronger ISH
signal and immunoreactivity for a1-, b2-, c1- and c2-
subunits than the striatum and nucleus accumbens
(Figs. 10–12; Table 5).
Distribution of GABAA receptor subunits in the
mouse diencephalon (thalamus, hypothalamus and
epithalamus)
In Fig. 13 and Table 6 the distribution and labeling
intensities of the 12 subunits investigated in the thalamic
Fig. 9. Distribution of the GABAA receptor (A) subunit mRNAs and (B) immunoreactivities (a1–a5, b1–b3, c2 and d) in the ventral hippocampus,
ventral subiculum (VS), parasubiculum (PaS) and presubiculum (PrS) and entorhinal cortex (Ent). Note the strong labeling of the a3-subunit mRNA
and protein in VS, PaS and PrS, in contrast to the weak labeling in CA1 and missing labeling in the dentate gyrus. The a5-unit is strongly expressed
in CA1–CA3, but faint in VS, PaS and PrS. Note the exclusive expression of the d-subunit in the dentate gyrus (horizontal sections of the mouse
brain approximately Bregma 3.28 mm, according to Franklin and Paxinos, 2007). Scale bar = 300 lm.
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extremely rich in mRNA (Table 6) and protein of a1-,
a4-, b2- and d-subunits (Fig. 13). All other subunits
were less abundant. No signals for the a6-subunit were
detectable. Interestingly, the paraventricular thalamic
nucleus was the only thalamic area containing mRNA
and immunoreactivity of all subunits except the
a6-subunit. The reticular thalamic nucleus exhibited a
distinct subunit repertoire. The highest labeling both ofISH and IHC was achieved for the a3-subunit,
associated with a much weaker labeling for the b1- and
c1-subunits. In contrast to most other thalamic nuclei
the reticular nucleus was almost devoid of labeling for
a1, a4, b2 and d.
Comparable to the rat brain, a remarkable segregation
of GABAA receptor subunit distribution was observed
between the dorsal lateral geniculate nucleus and the
pregeniculate nucleus (Fig. 14; Table 6). Both
Table 4. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d in
various regions of the mouse hippocampus
Hippocampus a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Dentate gyrus ++(+) ++ +++ +++ – – +++ +++ +(+) ++ – –
Hilus + ++(+) + + – + – – – – – –
CA1 +++ +++ ++ + + + +(+) + ++ ++(+) – –
CA2 ++ +(+) +++ ++ + (+) +(+) + +++ +++ – –
CA3 + + +++ +++ – (+) ++ + +++ +++ – –
Ventral subiculum +++ +++ +++ ++ +++ +++ + + + + – –
Dorsal subiculum +++ +++ (+) (+) +++ + + ++ (+) (+) – –
Parasubiculum ++(+) +++ + + +(+) ++ +(+) +++ + ++ – –
Presubiculum ++(+) +++ ++(+) + +(+) ++ +(+) +++ + ++ – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Dentate gyrus +++ +++ +++ ++ +++ +++ – – +++ +++ ++ ++(+)
Hilus + + + +(+) + – – – (+) (+) – –
CA1 +++ +++ ++ +(+) +++ ++(+) – – ++ ++ (+) (+)
CA2 +++ ++ ++ + +++ ++ – – ++ ++ – –
CA3 +++ +++ ++ + +++ +++ – – ++ ++ – –
Ventral subiculum ++ +++ +++ ++ +++ ++ – – +++ +++ – –
Dorsal subiculum + + +++ +++ + ++ – – + ++ – –
Parasubiculum ++ ++ +++ ++ ++ ++ – – +++ ++(+) + +
Presubiculum ++ ++ +++ ++ ++ ++ – – ++(+) ++(+) + +
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling.
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subunits both at the mRNA and protein level with the
highest intensity in the dorsal part. Labeling for a4- and
d-subunits was extremely strong in the dorsal lateral
geniculate nucleus with only a faint intensity in the
pregeniculate area. In contrast, labeling for subunits a2,
a3, b1, b3 and c2 was much less intense in the dorsal
lateral geniculate nucleus and more concentrated in the
pregeniculate nucleus.
In the medial habenula the most prominent subunit
was the a2-subunit both at the mRNA and protein level
associated with moderate ISH signal but missing
immunoreactivity for the b1- and c2-subunits. The
lateral habenula was characterized by the presence of
a1-, a2-, a3-, b1- and c1-subunits (Table 7).
The distribution and labeling intensities of the 12
subunits investigated in the hypothalamic nuclei are
summarized in Table 7. Besides the missing expression
of the a6-subunit labeling for the a4- and d-subunits
was hardly detectable both on the mRNA and protein
level. All other subunits were distributed all over the
hypothalamus. Comparable to the rat (Pirker et al.,
2000) the subunit a1, b2 and c2-antibodies labeled
most parts of the hypothalamus associated with a
corresponding intensity of ISH. The b1-subunit was
highly expressed in most parts of the hypothalamus
both at the mRNA as well as the protein level, a ﬁnding
contrasting with ISH data (Wisden et al., 1992) but well
agreeing with the protein expression of the rat
hypothalamus (Pirker et al., 2000). Remarkably, in
contrast to most other brain areas, the ISH signal for
the c1-subunit was considerably high throughout the
hypothalamus similar to the rat hypothalamus (Wisden
et al., 1992).Distribution of GABAA receptor subunits in the
mouse amygdala
Male C57BL/6NCrl mice revealed a similar distribution of
GABAA receptor subunit mRNAs in the amygdaloid nuclei
as previously described for CD1 and C57BL/6J mice
(Heldt and Ressler, 2007a,b; Tasan et al., 2011). As
shown in Fig. 15 and Table 8, expression for GABAA
receptor subunits a1, a2, a3, b3 and c2 was high.
Subunits a1 and b2 mRNA were preferentially detected
in the lateral and basolateral amygdala. Low expression
was observed for subunits a4, a5 and d. Subunit c1
mRNA was restricted to the central and medial
amygdaloid nucleus (Fig. 15). Also GABAA receptor
protein was rather equally distributed in many instances.
Subunits a1-, b2- and c2-immunoreactivities, however,
were only weakly expressed in the central nucleus, in
contrast to the comparably high staining for subunits a2,
a3, a4, b1 and c1 protein in this nucleus. Subunits a3-,
a4- and d-immunoreactivities were strongly expressed
in the intercalated cell masses, whereas these cell
groups appeared to be devoid of a1, b1 and c2 (Fig. 16).Distribution of GABAA receptor subunits in the
mouse cerebellum
The cerebellum was characterized by high concentrations
and a wide heterogeneity of most GABAA receptor
subunits as demonstrated by ISH and IHC (Figs. 17 and
18; Table 9). In agreement with the subunit distribution
in rat cerebellum the granule cell layer of the mouse
cerebellum displayed high concentrations of the a1-,
a6-, b2-, b3-, c2-, and d-subunits concerning both
mRNA and protein. In contrast, ISH signals and
Fig. 10. Distribution of the GABAA receptor subunit mRNAs (a1–a6, b1–b3, c1, c2 and d) in the striatum (St) and globus pallidus (GP; coronal
sections of the mouse brain approximately Bregma 0.34 mm, according to Franklin and Paxinos, 2007). The subunits a2, a4, b3 and d were
considerably more concentrated in St than in GP, whereas in situ hybridization signal for a1-, b2-, c1- and c2-subunits are much stronger in GP than
in St. Scale bar = 400 lm.
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layer for a2-, a3-, a4-, a5-, b1- and c1-subunits (Fig. 18).
In the Purkinje cell layer strong ISH signals were
apparent for the a1-, b2-, and c2-subunits and modest
signals for a4-, b1- and c1-subunits. In contrast to
rat cerebellum a strong immunoreactivity was detected
for a3- and extraordinarily for a4-subunits.
Immunoreactivity for b1- and c2-subunits was modest.
The remaining subunits revealed no or only faint
labeling of the Purkinje cells (Fig. 18).
In the molecular layer rather weak ISH signals
occurred for a1-, a2-, b2-, c1- and c2-subunits and no
labeling for the remaining subunits. Concerning the
protein distribution, in contrast to the rat, the strongest
immunoreactivity was conﬁned to the a4-subunit.
Comparatively high immunoreactivity was found for a1-,
a2-, b1- and b2-subunits and modest to weak labeling
for a5-, b3-, c2- and d-subunits.Distribution of GABAA receptor subunits in the
mouse olfactory bulb
The distribution of mRNA and protein labeling for the
GABAA receptor subunits are summarized in Figs. 19
and 20 as well as in Table 10. ISH revealed a strong
and layer speciﬁc labeling for all subunits except for a6
and a very faint labeling for c1. A comparable
distribution pattern was obtained for a1-, a3-, b2- and
c2-subunits, namely strong signals in mitral cell layer
and glomerular layer and a weak or almost no signal in
the granular cell layer. A comparable distribution for ISH
signals was observed for a2-, a5-, b3- and d-subunits
revealing a strong labeling of the granular layer.
On the protein level a comparable labeling pattern was
obtained for a1-, a3-, b2- and c2-subunits, namely strong
signals in the external plexiform layer and glomerular layer
and only a weak labeling in the granular layer. A strong
Fig. 11. Distribution of the GABAA receptor subunit immunoreactivities (a1–a6, b1–b3, c1, c2 and d) in the striatum (St) and globus pallidus (GP;
coronal sections of the mouse brain approximately Bregma 0.34 mm, according to Franklin and Paxinos, 2007). The distribution of the subunits
protein very well agrees with that of the mRNA. Scale bar = 400 lm.
358 H. Ho¨rtnagl et al. / Neuroscience 236 (2013) 345–372labeling of the mitral cells only occurred for the a3-subunit.
In the granular cell layer a strong labeling for a5- and b3-
subunits andmoderate labeling fora2- and d-subunits was
seen. Interestingly, in the external plexiform layer the
presence of most subunits was proven with the
exception of a6- and c1-subunits. For the b1-subunit
only the inner half of the external plexiform layer was
strongly labeled (for more details see Fig. 20; Table 10).DISCUSSION
The present study provides, for the ﬁrst time, a
concomitant comprehensive analysis of the mRNA and
protein distribution of 12 GABAA receptor subunits, a1–
a6, b1–b3, c1, c2 and d in the mouse brain. Ourﬁndings mostly conﬁrm the mRNA distribution pattern of
seven GABAA receptor subunit mRNAs (a1–a3, a5, b2,
b3 and c2) previously described in the forebrain and
midbrain (Heldt and Ressler, 2007a). Our data are also
consistent with previous reports on the distribution of
some of the mouse GABAA receptor subunit proteins in
the amygdala (Tasan et al., 2011), hippocampus (Peng
et al., 2004; Sassoe`-Pognetto et al., 2009), thalamus
(Peng et al., 2002) and cerebellum (Jones et al., 1997).
Moreover, the presented anatomical localization of the
b2-subunit in thalamus and dentate gyrus is in good
agreement to the electrophysiological ﬁndings of Belelli
et al. (2005) and Herd et al. (2008), who conﬁrmed the
b2-subunit gene expression by using b2-subunit gene
knockout and knock-in point mutations.
Fig. 12. Distribution of the GABAA receptor subunit immunoreactivities (a1, a3, a4, a5, b1, b2, c1 and d) in the entopeduncular nucleus (EP;
coronal sections of the mouse brain approximately Bregma 1.22 mm, according to Franklin and Paxinos, 2007). A strong immunoreactivity in EP
was observed for a1-, a5, b1-, b2- and c1-subunis. Scale bar = 150 lm.
H. Ho¨rtnagl et al. / Neuroscience 236 (2013) 345–372 359One of the aims of the present study was to deﬁne the
location of the synthesis and ﬁnal location of the protein of
each individual subunit by juxtaposition of ISH and IHC. Asecond aim was to analyze possible diﬀerences in the
distribution of the 12 subunits investigated between
mouse and rat brains. Moreover, we tried to deﬁne
Table 5. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d in various regions of the mouse basal ganglia and septal
and basal forebrain
Basal ganglia a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Caudate putamen (+) + ++ ++ – (+) +++ +++ – + – –
N. accumbens core (+) (+) +++ ++ – (+) ++ +++ – – – –
N. accumbens shell (+) (+) +++ ++ + (+) ++ +++ – – – –
Globus pallidus +++ +++ + + + (+) – – – (+) – –
Ventral pallidum +++ +++ – – – (+) – – (+) + – –
Entopeduncular nuc ++ ++ – (+) – (+) – (+) – + – –
Subthalamicus +++ ++(+) + + ++(+) ++ – (+) – + – –
Substantia nigra ret +++ +++ – + + + (+) (+) – (+) – –
Substantia nigra comp ++ + – + + + – (+) – (+) – –
Septal and basal forebrain
Lateral septum + + +++ +++ ++ ++ + +++ + +(+) – –
Medial septum ++(+) ++ + – ++ – (+) – – – – –
Bed nuc stria terminalis – + ++ +++ ++ +++ (+) + + + – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Caudate putamen + (+) + + ++ ++(+) (+) + + + +++ +++
N. accumbens core ++ (+) +(+) + ++ +(+) (+) (+) + – +++ ++
N. accumbens shell + (+) +(+) + ++ +(+) (+) (+) + – +++ ++
Globus pallidus (+) + +++ ++ – – ++ +++ +(+) + – –
Ventral pallidum – (+) +++ ++ – – + +++ ++ + – –
Entopeduncular nuc – +(+) ++ ++ – – – + – (+) – –
Subthalamicus (+) +(+) ++ +++ – + – – ++ +(+) – +
Substantia nigra ret + (+) +++ + – – + (+) +(+) (+) – –
Substantia nigra comp + (+) +++ +++ – – + (+) +(+) (+) – –
Septal and basal forebrain
Lateral septum +++ +++ +(+) ++(+) +++ ++ ++ ++ +(+) + – –
Medial septum + – +++ ++ – – (+) – +++ (+) – –
Bed nuc stria terminalis +++ +++ + + ++ + ++ + ++ + – –
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling; nuc = nucleus; ret = reticularis; comp= compacta.
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Fig. 13. Distribution of the GABAA receptor subunit immunoreactivities (a1–a5, b1–b3, c1, c2 and d) in the thalamus (coronal sections of the
mouse brain approximately Bregma 1.58 mm, according to Franklin and Paxinos, 2007). Most thalamic nuclei are extremely rich in protein of a1-,
a4-, b2- and d-subunits. The paraventricular thalamic nucleus (PV) is the only thalamic area containing immunoreactivity of all subunits except the
a6-subunit. The reticular thalamic nucleus (Rt) is characterized by a high expression of the a3-subunit. Scale bar = 500 lm. Hb = habenula,
LD = laterodorsal thalamic nucleus, PV = paraventricular thalamic nucleus, Rt = reticular thalamic nucleus, VPL = ventral posterolateral thalamic
nucleus, VPM= ventral posteromedial thalamic nucleus.
H. Ho¨rtnagl et al. / Neuroscience 236 (2013) 345–372 361co-distributions of speciﬁc subunits and to compare these
between mouse and rat brains.Diﬀerences in the distribution of mRNA and protein
There is general consensus that the location of mRNA not
always reﬂects that of the protein. In the present study we
diﬀerentiate whether the protein is located at the cell
soma or in dendrites or axon terminals far from the cell
body where the mRNA resides. Diﬀerences in the
location of ISH and immunohistochemical signals for the
12 subunits investigated were observed most frequentlyin diﬀerent parts of the hippocampus, the bulbus
olfactorius, cerebellum and habenula. Thus, in the
hippocampus ISH signals were restricted to the
pyramidal cell layer of CA1 to CA3, the granule cell
layer and hilus of dentate gyrus, whereas GABAA
receptor subunit proteins were predominantly located in
the strata oriens and radiatum of CA1 to CA3 and in the
molecular layer of the dentate gyrus and hilus. This
implies that the GABAA receptor subunits are
predominately targeted to dendrites of granule cells,
pyramidal cells and interneurons of these layers. In the
hilus of the dentate gyrus the presence of subunits
Table 6. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d in various regions of the mouse thalamus
Thalamus a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Anteroventral nuc ++ +++ – + + – +++ +++ – + – –
Anterodorsal nuc +++ +++ – – + + +++ +++ – + – –
Anteromedial nuc ++ +++ – – + – +++ +++ – – – –
Parafascicular thal nuc ++ ++ + + +++ ++ + – – –
Post. Thalam. nuclei ++(+) +++ – – – – +++ ++ – – – –
Ventromedial area ++(+) ++ – – – – +++ ++ – ++ – –
Ventrolateral nuc +++ +++ – – – – +++ ++ – – – –
Mediodorsal nuc +++ ++ – – ++ – +++ +++ – + – –
Laterodorsal nuc +++ +++ + +(+) + +(+) +++ +++ – – – –
Reticular nuc – – – + ++(+) ++(+) – – – (+) – –
Paraventricular thal nuc + +++ ++ ++ +++ +++ +++ ++(+) +(+) +(+) – –
Central medial thal nuc + +++ + – ++ + +++ ++ – – – –
Centrolateral thal nuc + ++ – – + + +++ ++ – – – –
Reuniens thal nuc + ++ + + ++ +(+) +++ ++(+) (+) – – –
Dorsal geniculate nuc ++ +++ + + (+) + +++ +++ (+) (+) – –
Perigeniculate nuc ++ +++ +(+) ++ ++ ++ (+) (+) (+) + – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Anteroventral nuc +++ +++ +++ +++ (+) (+) – (+) + – +++ +++
Anterodorsal nuc +++ +++ +++ +++ (+) + – + +(+) – +++ +++
Anteromedial nuc ++ – +++ +++ (+) + – (+) + – +++ +++
Parafascicular thal nuc +++ – +++ +(+) – – – – +(+) – + ++
Post. Thalam. nuclei ++ – +++ + – – – – + – +++ +++
Ventromedial area + – +++ + – + – (+) + – +++ +++
Ventrolateral nuc + – +++ +++ – – – (+) + – +++ +++
Mediodorsal nuc +++ – +++ + – + (+) (+) ++ – +++ +++
Laterodorsal nuc +++ + +++ ++ – + – +(+) + + +++ +++
Reticular nuc + + – (+) – (+) – + + – – –
Paraventricular thal nuc +++ +++ + +(+) +(+) + + + ++(+) + +(+) +
Central medial thal nuc ++(+) + + + + + + + ++ – +++ +
Centrolateral thal nuc +(+) + + + – (+) – – + – +++ +
Reuniens thal nuc +(+) + + +++ + + + + + – + +(+)
Dorsal geniculate nuc + + ++(+) +++ (+) + – – +(+) + +++ +++
Perigeniculate nuc + ++ ++ ++ (+) + – – +(+) +(+) (+) (+)
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling; nuc = nucleus; thal = thalamic.
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Fig. 14. Distribution of the GABAA receptor (A) subunit mRNAs and (B) immunoreactivities (a1–a5, b1–b3, c2 and d) in the dorsal lateral geniculate
nucleus (DLG) and pregeniculate nucleus (PG; coronal sections of the mouse brain approximately Bregma -2.70 mm, according to Franklin and
Paxinos, 2007). The distribution of the subunits protein very well agrees with that of the mRNA. Note the clear co-distribution of a4- and d-subunits.
Only a1- and b2-subunits were detected in both nuclei. Scale bar = 400 lm.
H. Ho¨rtnagl et al. / Neuroscience 236 (2013) 345–372 363(mRNA and protein) was mainly conﬁned to subunits a1,
a2, b1 and b2. In addition faint signals for b3- and c2-
subunit mRNAs were detected.
In the amygdala the rather high expression of the c1-
subunit mRNA in the medial amygdaloid nucleus was
associated with only weak immunolabeling.In the bulbus olfactorius diﬀerences in the
distribution of mRNA and protein of the various
subunits were especially observed in the external
plexiform layer and mitral cell layer. In the external
plexiform layer a rather weak ISH signal associated
with a strong immunohistochemical label was found
Table 7. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d in
various regions of the mouse hypothalamus and epithalamus
Hypothalamus a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Preoptic area +(+) +++ +++ ++ ++ +++ (+) (+) ++ +++ – –
Lateral hypothalamic area +(+) ++ ++ + ++ ++(+) + + + ++ – –
Anterior hypothalamus +(+) +(+) +++ + ++(+) + + + + +(+) – –
Posterior hypothalamus ++(+) + + + ++(+) + – – + + – –
Paraventricular nuc + + +++ +(+) + + – – (+) + – –
Arcuate nuc + – + ++ +++ ++ – (+) ++ +(+) – –
Ventromedial nuc ++ +++ ++ +++ +++ +++ + + ++ ++ – –
Dorsomedial nuc + ++ + + ++(+) + – – + +(+) – –
Mamillary nuclei + +++ +(+) ? + + (+) – +(+) +(+) – –
Epithalamus
Medial habenular nuc – – +++ + – (+) – – – – – –
Lateral habenular nuc + + + (+) + (+) – – – – – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Preoptic area +++ +++ ++ (+) ++(+) + ++ +(+) +++ (+) + –
Lateral hypothalamic area +(+) ++ + + + ++ + ++ + – –
Anterior hypothalamus +++ +++ +(+) ++ ++ ++(+) +++ + ++ ++ – –
Posterior hypothalamus +(+) + +(+) (+) + (+) – +++ (+) – –
Paraventricular nuc +(+) +(+) + (+) + + + + +++ + – –
Arcuate nuc + + – + – +(+) ++ + + (+) – –
Ventromedial nuc ++ (+) +(+) (+) + +(+) + + + – –
Dorsomedial nuc +++ +++ +(+) + +++ ++ +++ +(+) +++ +++ – –
Mamillary nuclei +(+) + + (+) + + + + +++ + – –
Epithalamus
Medial habenular nuc + – – – (+) – – (+) +(+) – – –
Lateral habenular nuc + + – (+) (+) – +(+) + + – – (+)
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling; nuc = nucleus.
364 H. Ho¨rtnagl et al. / Neuroscience 236 (2013) 345–372for all subunits expressed in the bulbus olfactorius. In
contrast, in the mitral cell layer a high level of mRNA
associated with a faint or low immunohistochemical
label occurred for the subunits a1, a5, b1, b2, b3, c2
and d. These ﬁndings indicate that GABAA receptor
subunits synthesized in the cell bodies of mitral cells
are transported to the inhibitory dendrodendritic
synapses formed with dendritic spines of granule cells
in the external plexiform layer as well as with nerve
terminals of periglomerular neurons in the glomerular
layer (Schoppa and Urban, 2003; Sassoe`-Pognetto
et al., 2009). Our data on the distribution of a1- and
a3-subunits IHC in the external plexiform layer conﬁrm
the previous data by Sassoe`-Pognetto et al. (2009)
demonstrating a uniform distribution of the a1-subunit
throughout the external plexiform layer, but a more
abundant expression of the a3-subunit in the
superﬁcial one-third of the external plexiform layer
containing the dendrites of middle and external tufted
cells. Moreover, the strong protein expression of a5-,
b1-, b2-, b3- and c2-subunits and moderate
expression of a2-, a4- and d-subunits in the external
layer, demonstrated in the present study, indicate the
involvement of various GABAA receptor subtypes in
the dendrodendritic inhibition of mitral and tufted cells
by granule cells. This similarly refers to the glomerular
layer.In the medial habenular nucleus a strong ISH signal
for the a2- and c2-subunits was not followed by an
immunohistochemical signal. In the medial septum a
moderate presence of a3-mRNA as described
previously (Heldt and Ressler, 2007a) has been
conﬁrmed. However the a3-mRNA expression was not
associated with the corresponding presence of the a3-
protein. Likewise, for the c2-subunit in the medial
septum a strong ISH signal, but in contrast to the rat
septum only a faint immunohistochemical signal existed.Diﬀerences in the distribution of GABAA receptor
subunits between mouse and rat brains
To analyze possible diﬀerences in the distribution of the
12 subunits investigated between mouse and rat brains,
distributions of mRNA and protein in the rat brain
described by Wisden et al. (1992) and Laurie et al.
(1992) and by Sperk et al. (1997) and Pirker et al.
(2000), respectively, were used. Comparing the overall
distribution of GABAA receptor subunit
immunoreactivities in the rat (Pirker et al., 2000: Fig. 1)
and mouse (Fig. 6) some apparent diﬀerences are
obvious. Thus immunolabeling of subunits a1, b1, and
c2 appeared to be somewhat stronger in the rat than in
the mouse, whereas labeling for a4 and d was generally
stronger in the mouse brain. These diﬀerences may
Fig. 15. Distribution of the GABAA receptor subunit mRNAs (a1–a5, b1–b3, c1, c2 and d) in the amygdala (coronal sections of the mouse brain
approximately Bregma 1.58 mm, according to Franklin and Paxinos, 2007). Scale bar = 500 lm. In the bottom right a schematic drawing adapted
from Franklin and Paxinos, 2007 is included. CEA = central amygdala, BLA = basolateral amygdala, I = intercalated nucleus. Note preferential
presence of the subunits a1 and b2 mRNA in the lateral and basolateral amygdala. Low expression is visible for subunit a4, a5 and d. Subunit c1
mRNA is restricted to the central and medial amygdaloid nucleus.
Table 8. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d in
various regions of the mouse amygdala
Amygdala a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Central nuc – – +++ +++ ++ +++ + +++ + +++ – –
Basomedial nuc + ++(+) ++ ++ +++ ++ + +(+) +(+) ++ – –
Basolateral nuc ++ +(+) +++ ++ +++ ++ + + ++ + – –
Lateral nuc +++ +++ ++ ++ + ++ + + +(+) + – –
Intercalate nuc – +(+) +++ ++(+) ++
Medial nuc +(+) ++ +++ ++ +++ +++ +(+) ++ + ++ – –
Anterior cortical nuc ++ ++ + ++ +++ ++ + ++ +(+) ++ – –
Posterior cortical nuc ++ ++ + ++ +++ ++ + ++ +(+) ++ – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Central nuc +++ +++ – (+) +++ +++ +++ +++ (+) (+) – +
Basomedial nuc ++ ++ ++ ++ + +++ ++ + ++ ++ – –
Basolateral nuc ++ ++ ++ ++ ++ ++(+) (+) ++ ++ ++ – –
Lateral nuc ++ ++(+) ++ +++ + ++(+) (+) + ++ +++ – –
Intercalate nuc (+) + +++ (+) + +(+)
Medial nuc +++ ++(+) +(+) ++ ++ +++ ++ + +(+) +(+) – (+)
Anterior cortical nuc ++ ++ +++ ++(+) ++ ++(+) + + ++ +(+) + +
Posterior cortical nuc ++ ++ +++ ++(+) +++ ++(+) + + ++ +(+) + +
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling; nuc = nucleus.
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Fig. 16. Distribution of the GABAA receptor subunit immunoreactivities (a1–a5, b1–b3, c1, c2 and d) in the amygdala (coronal sections of the
mouse brain approximately Bregma 1.58 mm, according to Franklin and Paxinos, 2007). Scale bar = 500 lm. In the bottom right a schematic
drawing adapted from Franklin and Paxinos, 2007 is included. CEA = central amygdala, BLA = basolateral amygdala, I = intercalated nucleus,
MA=medial amygdaloid nucleus. The distribution of the subunits protein very well agrees with that of the mRNA with, e.g. no or only faint
immunoreactivity for the subunits a1, b2 and c2, but a relatively strong labeling for subunit c1 in the central amygdala.
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receptor subunits, or may be due to technical diﬀerences
in the two studies. Although we used mostly similar but
not identical antisera for both studies, the individual
antisera in the individual incubations may yield diﬀerent
results in respect to the intensities of labeling.
Moreover, it has to be pointed out that diﬀerences in
staining intensities do not necessarily reﬂect diﬀerences
in actual subunit concentrations.
In the hippocampus several diﬀerences were obvious.
In the dentate gyrus of the mouse, the a3-subunit was not
expressed both at the mRNA and protein level. On the
other hand an obviously much higher protein expression
for the a5- and a higher expression for the d-subunit
were observed in the mouse as compared to rat in
the dentate gyrus. In the CA3 area, the
immunohistochemical label for a1-, b2- and d-subunits
was much weaker in the mouse than in the rat. The
hippocampal distribution of the a3-subunit in the mouse
diﬀered strikingly from that in the rat. Whereas in the rat
hippocampus mRNA and protein labeling was almost
exclusively detected in the dentate gyrus and CA3
(Wisden et al., 1992; Pirker et al., 2000), a3-subunit
mRNA and protein labeling in the mouse hippocampus
was almost restricted to the CA1 area. Despite the
weak and exclusive expression of the a3-subunit in CA1of the mouse hippocampus, a strong signal both at the
mRNA and protein level occurred in the ventral
subiculum, parasubiculum and presubiculum, a
distribution, which was not seen in the rat. In the
hippocampus the labeling of d-subunit mRNA and
protein was most prominent in the dentate gyrus of rat
and mouse. However, in the rat subiculum a moderate
d-subunit immunoreactivity in cell bodies and diﬀuse
staining was described (Pirker et al., 2000), which was
not detected in the mouse subiculum.
In contrast to the rat hypothalamus immunolabeling of
the d-subunit was not detectable throughout the
hypothalamus in the mouse. The absence of d-subunit
protein has been reported previously (Peng et al.,
2002). Comparable to the mouse hypothalamus, d-
subunit mRNA was not detectable in the rat
hypothalamus according to Wisden et al. (1992).
Among the thalamic nuclei the rat reticular thalamic
nucleus displayed high intensities of a3-, b1-, b3- and
c2-subunit-immunoreactivities, whereas in the mouse
reticular thalamic nucleus the high intensity of a3-
subunit-labeling was associated with a much weaker
labeling of a2-, b1-, and c1-subunits both at the mRNA
and protein level (Table 6).
In the amygdala the most obvious mouse-rat-
diﬀerences were observed in the central nucleus,
Fig. 17. Distribution of the GABAA receptor subunit mRNAs (a1–a6, b1–b3, c1, c2 and d) in the cerebellum (horizontal sections of the mouse brain
approximately Bregma 3.28 mm, according to Franklin and Paxinos, 2007). The mouse cerebellum displays high concentrations of the a1-, a6-,
b2-, b3-, c2, and d-subunits mRNA. Note the co-distribution of a6- and d-subunits. Scale bar = 1 mm.
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c2-subunits occurred in the mouse contrasted by a
strong labeling in the rat. In addition, a considerably
stronger expression of the a3-subunit in the mouse
central and basolateral nucleus was observed both at
the mRNA and protein level as compared to rat
amygdala. The immunolabeling of the a5-subunit
revealed a much stronger signal in the central nucleus
than in the basolateral amygdala, a diﬀerence which
was not described in the rat amygdala (Pirker et al.,
2000). The strong immunolabeling of the c1-subunit in
the medial amygdaloid nucleus detected in the rat
(Pirker et al., 2000) was not visible in the mouse
(Fig. 16).
In the cerebellum the most striking diﬀerence was
the strong protein signal for a3-, a4- and c2-subunits
in the Purkinje cell layer, but almost no labeling in the
Purkinje cell layer of the rat (Laurie et al., 1992;
Pirker et al., 2000). In the molecular layer of the
mouse cerebellum the strongest immunoreactivity was
conﬁned to the a4-subunit, which highly contrasts thedistribution of the a4-subunit protein in the rat
cerebellum. In the mouse cerebellum rather faint a5-
subunit protein was located in the Purkinje cell layer,
whereas in the rat cerebellum a5-subunit protein has
been demonstrated to be distributed in all three
layers, with a stronger labeling of the molecular layer
(Pirker et al., 2000).
In the bulbus olfactorius mouse versus rat
diﬀerences were observed especially in the mitral cell
layer and granular layer, where only weak
immunolabeling was found for a1-, b2- and c2-
subunits in the mouse, but strong labeling in the rat.
On the other hand a much stronger immunolabeling
existed for the a3- and a4-subunits in the mouse
mitral cell layer than in that of the rat. In contrast to
the rat, d-subunit protein was absent in the mouse
mitral cell layer. At the mRNA level striking diﬀerences
were seen especially for the distribution of a3-, a4-,
b1-, c2- and d-subunits in the mouse bulbus
olfactorius (Fig. 19, Table 10) in comparison to the rat
(Wisden et al., 1992; Laurie et al., 1992).
Fig. 18. Distribution of the GABAA receptor subunit immunoreactivities (a1–a6, b1–b3, c1, c2 and d) in the cerebellar cortex (horizontal sections of
the mouse brain approximately Bregma 3.28 mm, according to Franklin and Paxinos, 2007). Note the dark subunit a1-, a6- b2-, b3- and
d-immunoreactivity in the granule cell layer (Gr). In the Purkinje cell layer (Pu) a strong immunoreactivity can be seen for a3- and extraordinarily for
a4-subunits, but modest Immunoreactivity for a5-, b1- and c2-subunits. Molecular layer (Mol). Scale bar = 50 lm.
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various areas of the mouse brain
The co-distribution of GABAA receptor subunits is of
special interest, since the subunit composition deﬁnes
the synaptic or extrasynaptic localization and inﬂuences
the biophysical and pharmacological properties of
GABAA receptors. Thus, whereas a1-, a2- and c2-
subunit-containing receptors are mainly located within
the synapse and mediate phasic inhibition, a4-, a5-, a6-and c2- and d-subunit-containing receptors are often
located extrasynaptically mediating tonic inhibition.Co-distribution of a1-, b2- and c2-subunits. In the rat
brain a1-, b2- and c2-subunits are considered as the
most abundant GABAA receptor subunits (Pirker et al.,
2000; Sieghart and Sperk, 2002). Similarly, in the
mouse brain a co-distribution, intensity of labeling and/or
co-missing of these three subunits on the mRNA as well
Table 9. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d in
various regions of the mouse cerebellum
Cerebellum a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Molecular layer + ++ + +++ (+) + (+) ++ (+) (+) – +
Purkinje cell layer +++ – + – (+) +++ ++ ++ + + – (+)
Granule cell layer ++ +++ + + (+) (+) (+) – (+) (+) +++ +++
Cerebellar nuclei +++ +(+) – – + +(+) – – (+) (+) – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Molecular layer – ++ + ++ (+) + + +(+) + + (+) +
Purkinje cell layer ++(+) ++ ++ (+) ++ (+) (+) + +++ +(+) (+) (+)
Granule cell layer +(+) + +++ +++ ++ +++ (+) (+) ++ +(+) +++ +++
Cerebellar nuclei (+) (+) + + (+) (+) + + ++ + – (+)
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling.
Fig. 19. Distribution of the GABAA receptor subunit mRNAs (a1–a6, b1–b3, c1, c2 and d) in the bulbus olfactorius (horizontal sections of the mouse
brain approximately Bregma 3.60 to 3.28 mm, according to Franklin and Paxinos, 2007). In situ hybridization reveals a strong and layer speciﬁc
labeling for all subunits except for a6 and a very faint labeling for c1. Scale bar = 500 lm.
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refers to all layers of the bulbus olfactorius and
cerebellum (exception: higher immunolabeling for c2-
subunit in the rat). An excellent co-distribution of a1-,
b2- and c2-subunits with corresponding labeling
intensity was detected in all areas of the hippocampus
including ventral subiculum, parasubiculum and
presubiculum. Moreover, comparable labeling patterns
for these three subunits appeared throughout the basalganglia and the amygdala. With the exception of the
perigeniculate nucleus the staining intensity of the c2-
subunit in the thalamus was considerably lower than
that of the a1- and b2-subunits.
Co-distribution of a4- and d-subunits. As
demonstrated in the rat brain (Pirker et al., 2000)
subunit a4- and d-immunoreactivity displayed typical
patterns of co-distribution preferentially in the thalamus,
Fig. 20. Distribution of the GABAA receptor subunit immunoreactivities (a1–a5, b1–b3, c2 and d) in the bulbus olfactorius (horizontal sections of the
mouse brain approximately Bregma 3.60 to 3.28 mm, according to Franklin and Paxinos, 2007). Note the strong signals for a1-, a3-, b2- and c2-
subunits in the external plexiform layer (EPI) and glomerular layer (Gl), and only a weak labeling in the granular cell layer (gr). A strong labeling of
the mitral cell layer (Mi) only occurs for the a3-subunit. In gr a strong labeling for a5- and b3-subunits and moderate labeling for a2- and d-subunits
is visible. Scale bar = 50 lm.
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distribution is extended in the mouse to the bulbus
olfactorius both at the mRNA and protein level.
However, in the granule cell layer of rat cerebellum it is
well established that the d-subunit no longer co-localizes
with the a4-subunit, but is associated with the a6- and
b2/3-subunits in extrasynaptic location (Nusser et al.,
1998; Pirker et al., 2000). This co-distribution, speciﬁc
for the cerebellum, has also been demonstrated in the
mouse cerebellum (Jones et al., 1997) and was nowconﬁrmed both by ISH and IHC. Notably, evidence has
been provided that a6-subunit gene inactivation inhibits
the expression of the d-subunit in the membrane without
changing levels of d-subunit mRNA (Jones et al., 1997).
The inhibition of d-subunit expression was underlined by
the almost total loss of high-aﬃnity binding of
[3H]-muscimol, a selective autoradiographic probe for
a6- and d-subunit association, from the cerebellar
granule cell layer in the a6-subunit/ mice (Jones
et al., 1997).
Table 10. Density of in situ hybridization (ISH) and immunohistochemical (IHC) labelings for the GABAA receptor subunits a1–a6, b1–b3, c1, c2 and d
in various regions of the mouse bulbus olfactorius
Bulbus olfactorius a1 a2 a3 a4 a5 a6
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Glomerular layer +(+) +++ (+) ++ +++ +++ (+) + (+) (+) – –
Ext. plexiform layer + +++ + +++ + +++ + ++ + +++ – –
Mitral cell layer +++ (+) + (+) +++ +++ ++ ++ ++ + – –
Granular cell layer – + ++(+) ++ + + ++ ++ ++ +++ – –
b1 b2 b3 c1 c2 d
ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC ISH IHC
Glomerular layer + + +(+) +++ ++ +++ (+) (+) +++ ++ +(+) +(+)
Ext. plexiform layer + +++ + +++ + +++ (+) (+) + +++ + ++
Mitral cell layer ++ (+) +++ (+) ++ + (+) + +++ (+) ++ (+)
Granular cell layer ++ (+) (+) (+) +++ ++ (+) (+) +(+) + +++ +(+)
– no labeling; (+) faint labeling; + weak labeling; ++ moderate labeling; +++ strong labeling.
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expressed independently of the presence of the
d-subunit in the lateral septum, central nucleus of the
amygdala and in the CA1–CA3 region of the mouse
hippocampus. This localization of the a4-subunit
independent of the d-subunit e.g. in the CA1 region
agrees with previous mRNA ﬁndings in the rat
hippocampus (Wisden et al., 1992).
CONCLUSIONS
In conclusion, the present data provide for the ﬁrst time a
clear overview on the localization of the GABAA receptor
subunits a1–a6, b1–b3, c1–c2 and d in the mouse
brain at the mRNA level as well as the protein level. In
diﬀerent brain areas we were able to demonstrate that
mRNA levels did not reﬂect protein levels, indicating that
the protein is located far distant from the cell body.
Moreover, although in general there is a considerable
correspondence in the anatomical distribution and co-
distribution of the 12 subunits investigated between
mouse and rat brains, several species-speciﬁc
diﬀerences have to be taken into account.
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